A series of mutants of equine herpesvirus-1 (EHV-1) which contain deletions in non-essential genes was previously characterized in a murine intranasal infection model. One mutant, ED71 which was shown to be attenuated in the model, was further characterized by inoculation into pregnant mice. Despite the attenuation previously reported, intranasal inoculation of pregnant mice resulted in premature parturition and the birth of dead or dying foetuses. Furthermore, mice inoculated before pregnancy with the same mutant, and subsequently challenged 14 days after conception with wild-type virus, were not protected from abortion.
A series of mutants of equine herpesvirus-1 (EHV-1) which contain deletions in non-essential genes was previously characterized in a murine intranasal infection model. One mutant, ED71 which was shown to be attenuated in the model, was further characterized by inoculation into pregnant mice. Despite the attenuation previously reported, intranasal inoculation of pregnant mice resulted in premature parturition and the birth of dead or dying foetuses. Furthermore, mice inoculated before pregnancy with the same mutant, and subsequently challenged 14 days after conception with wild-type virus, were not protected from abortion.
Equine herpesvirus-1 (EHV-1) is an important pathogen of horses, causing pyrexia and clinical signs of respiratory disease (Allen & Bryans, 1986 ). However, one of the most important sequelae is abortion (Chowdry et al., 1986) , which results in serious economic loss to the thoroughbred-horse industry. The pathogenesis of abortion is thought to involve viraemia during acute infection and infection of endothelial cells of the small and medium-sized blood vessels of the placenta. Vaccines have been developed in an attempt to control EHV-1 disease ; however, to date, they have failed to confer lasting protection and have not always prevented abortion.
Large-scale infection experiments in pregnant horses are expensive and undesirable on welfare grounds. Furthermore, the uncertain infection status of naturally reared animals means that results are difficult to interpret. Laboratory models are therefore required for initial studies prior to confirmatory work in the natural host. An intranasal murine abortion model has been described in which pregnant mice are inoculated intranasally with EHV-1 on the 16th day after conception (Awan et Author for correspondence : Hugh J. Field.
Fax j44 1223 332998. e-mail hjf10!cam.ac.uk al., 1991) . Several days after virus inoculation the mice undergo premature parturition and expel dead or dying foetuses, some of which contain infectious virus. Furthermore, in a recent study virus-infected cells were detected by means of in situ hybridization within the endothelial cells lining blood vessels in the placenta of affected animals (Awan et al., 1995) .
A series of deletion mutants has been generated in which various non-essential genes were replaced with a lacZ cassette (Sun & Brown, 1994) . Their pathogenicity in the murine intranasal infection model has been determined (T. Fitzmaurice and others, unpublished). One mutant (ED71) was found to be attenuated relative to the parental virus strain (EHV-1 Ab4p) (Marshall et al., 1997) . When mice that had survived infection with ED71 were subsequently challenged by inoculation of wild-type virus, the mutant-infected mice were found to have developed some protective immunity although this was not complete. In this report we used the murine intranasal abortion model to characterize the ED71 mutant further.
Rabbit kidney cells (RK-13) and baby hamster kidney cells (BHK-21) were used for the production of virus working stocks and for titration of infectious virus by plaque formation using standard methods. The mutant used in the study (EHV-1 ED71) contained a lacZ cassette under the control of an SV40 promoter, inserted into a 1811 bp deletion within ORF71 (Sun & Brown, 1994 ; Telford et al., 1992) . The ED71 mutant was derived from the plaque-purified strain EHV-1 Ab4p (Telford et al., 1992) which itself was derived from the Ab4 isolate. The latter was employed for challenge experiments with mice.
BALB\c mice were obtained from Bantin & Kingman at 4 weeks of age. Mice were inoculated intranasally under oxygen-isofluorane anaesthesia with 1i10' p.f.u. per mouse of Ab4p, ED71 or an equivalent volume of BHK cell lysate. At 10 weeks of age the mice were mated, pregnancy being confirmed by steady weight gain after development of a vaginal plug (Awan et al., 1991) .
On day 16 of pregnancy, mice were inoculated intranasally with either BHK cell lysate, ED71 or Ab4 at a dose of 3i10' p.f.u. per mouse in 40 µl or the equivalent volume of lysate. Thus, there were five experimental groups : a negative control group given doses of cell lysate only (n l 7), a positive control group given cell lysate as the first inoculation and Ab4 as the second (n l 5), a group that received cell lysate as the first inoculation and ED71 as the second (n l 5), a group given ED71 as the first inoculation and challenged with Ab4 (n l 5) and a final group that received Ab4p as the first inoculation and Ab4 as the second (n l 2) ( Table 1) .
Virus titration was carried out by plaque assay. Whole foetuses or placentas were homogenized and inoculated into RK-13 monolayer cultures in 10-fold serial dilution. Monolayers were examined for CPE. Cultures still negative after 7 days were suspended in medium, centrifuged at low speed to pellet the cells and repassaged on fresh monolayers. For cultures showing no CPE after 7 days the procedure was repeated.
Virus isolates from foetuses obtained from dams that been exposed to ED71 were assayed as follows : cultures were fixed in 4 % paraformaldehyde, washed in PBS and then placed in an X-Gal reaction solution, incubated for 18 h and examined for a blue colour (Marshall et al., 1997) . In samples from mice that had been infected during pregnancy with ED71, βgalactosidase staining was observed, whereas no staining was seen in those virus-positive samples from mice that had been inoculated with ED71 at 4 weeks of age and subsequently challenged during pregnancy with wild-type virus. This confirmed that the virus isolated was derived from the challenge inoculation, not the immunizing inoculation several weeks earlier.
Two important findings come from this study. First, the attenuated deletion mutant EHV-1 ED71 failed to provide protection from abortion caused by subsequent challenge with wild-type virus. Secondly, it was apparent that the mutant was itself capable of producing premature parturition and the birth of dead or dying foetuses.
Caution is required in extrapolation of these results to predict the outcome of infection or immunization in the natural host. Furthermore, this investigation examined only a single dose for immunization, rather than the more rigorous multidose regimen that has been employed for current EHV vaccines. Despite the anatomical differences in placentation, our studies do suggest that this abortion model may be valid for cautious comparison. There is some evidence from experiments using baculovirus recombinant EHV-1 glycoproteins as immunogens that these may be at least partially effective in preventing abortion in the same model (A. Kukreja and others, unpublished ; A. R. Awan and others, unpublished) . Another previous study provided support for the validity of the model. In this case, therapy with (S)-9-(3-hydroxy-2phosphonylmethoxypropyl)adenine (HPMPA) was capable of completely preventing abortion (Awan & Field, 1993 ). In the same paper, it was argued that the prevention of viraemia by means of the antiviral agent was the key factor in preventing abortion.
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We have not studied the ability of ED71 to produce viraemia in the murine model directly ; however, the detection of mutant virus in placenta and foetus in a number of cases suggests that this is likely. Furthermore, Marshall et al. (1997) showed using β-galactosidase detection that ED71 translocated to both the trigeminal ganglion and olfactory bulbs of nonpregnant infected mice during the acute infection. When a rationale has been developed for the deletion of specific genes that are involved in EHV-1 tissue tropisms (e.g. vascular endothelium and placenta, which are likely to be involved in abortion) it will be particularly interesting to study their pathogenesis in this or similar models as an adjunct to investigations in the natural host.
